Health Condition 1: L649- Androgenic alopecia, unspecified
Conditions
Interventions
Intervention1: Platelet rich plasma with activator: PRP will be prepared by collecting 18cc of fresh blood in sodium citrate containing vacutainer. The tube will rotated in a cectrifugation machine at
p with the help of insulin syringe.
Control Intervention1: PRP without activator: PRP will be prepared by collecting 18cc of fresh blood in sodium citrate containing vacutainer. The tube will rotated
p with the help of insulin syringe.
Sponsors
Institute of Medical Science Banaras Hindu University
Eligibility
Inclusion criteria
Inclusion criteria: Patient of androgenetic alopecia having Halminton norwood scale 2-5
Exclusion criteria
Exclusion criteria: All the patient using topical minoxidil finasteride and systemic finasteride for at least 3 month Patient not giving informed consent or unable to understand the protocol and uncooperative patients any inflammation erythema or scaling over scalp Patient who have history of malignancies platelet disorders anemia or bleeding disorder bone marrow aplasia uncontrolled diabetes sepsis and cancer Patient who are known to be HIV hepatitis B or C positive or immunocompromised Patients who have active skin disease or skin infection at the intended treatment area Patients with a propensity for keloids Patients on antiplatelet drug like aspirin or non steroidal anti inflammatory drugs Patients taking drugs known to cause alopecia like anticoagulants beta blocker ACE inhibitors OCP valproic acid lithium etc
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate hair counts hair density hair thicknessTimepoint: six months | — |
Secondary
| Measure | Time frame |
|---|---|
| Subjective assessment using questionaireTimepoint: six months | — |
Countries
India
Contacts
Public ContactShailesh Singh
Institute of Medical Sciences BHU
Outcome results
None listed